N-Acetylcysteine Improves Mitochondrial Function and Ameliorates Behavioral Deficits in the R6/1 Mouse Model of Huntington's Disease

Translational Psychiatry - United Kingdom
doi 10.1038/tp.2014.131
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CD200 Is Up-Regulated in R6/1 Transgenic Mouse Model of Huntington's Disease

PLoS ONE
Multidisciplinary
2019English

Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease

Journal of Neurophysiology
NeurosciencePhysiology
2006English

Corticosterone Dysregulation Exacerbates Disease Progression in the R6/2 Transgenic Mouse Model of Huntington's Disease

Experimental Neurology
Developmental NeuroscienceNeurology
2016English

Ubiquilin-1 Overexpression Increases the Lifespan and Delays Accumulation of Huntingtin Aggregates in the R6/2 Mouse Model of Huntington's Disease

PLoS ONE
Multidisciplinary
2014English

Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2019English

Early-Onset Behavioral and Synaptic Deficits in a Mouse Model of Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

N-Acetylcysteine Amide Confers Neuroprotection, Improves Bioenergetics and Behavioral Outcome Following TBI

Experimental Neurology
Developmental NeuroscienceNeurology
2014English

Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice

Neurobiology of Disease
Neurology
2001English

XJB-5-131-mediated Improvement in Physiology and Behaviour of the R6/2 Mouse Model of Huntington's Disease Is Age- And Sex- Dependent

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy